Efficacy and Safety of Low-Dose Protamine in Reducing Bleeding Complications during TAVI: A Propensity-Matched Comparison.
Kinan KneizehAndrea MilziFelix VogtKlaus K WitteNikolaus MarxMichael LehrkeMohammad AlmallaJörg SchröderPublished in: Journal of clinical medicine (2023)
In this propensity-matched retrospective analysis, a low-dose protamine regime is associated with a higher rate of major adverse events compared to a full-dose protamine regime following transfemoral TAVI.